Highlights
1 patent
About
Acute Decompensated Heart Failure Treatment
WhiteSwell Medical is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The company is developing a minimally invasive, catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid-removal process of the lymphatic system.
Identity
| Name | WhiteSwell Medical |
|---|---|
| Slug | whiteswell-medical |
| Type / kind | startup |
| Crunchbase ID | whiteswell |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKOUiL4LDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Shefayim |
| HQ address | Shefayim, Israel |
Web & social
| Website | https://whiteswell.com |
|---|---|
| https://www.linkedin.com/company/18936815 | |
| Twitter / X | https://twitter.com/WhiteswellLtd |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
cathetersminimally-invasivecardiovascularheart-failuremedical-devicesmedical-technologies
Funding
| Total raised | $30.0M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}